Yesterday we noted that Roche was getting set to launch their Solo patch pump. We also noted that there are a host of companies also jumping into the insulin pump pool. Yes, everyone seems to believe they have built a better mouse trap. Each time an insulin pump newbie enters this highly competitive market they state they will do something that has never been done before; increase pump usage for insulin using Type 2 patients.
Now never mind that no one and we mean no one not even mighty Medtronic has been able to do this. Still this hasn’t . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.